Physician profile
Adel B Soliman
NPI 1265433403
$3,837.86
in general payments reported to CMS, 2019-2025
20 companies · $76.25 in 2025
The $76.25 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,330 · 2020: $318 · 2021: $18.05 · 2022: $62.20 · 2024: $33.30 · 2025: $76.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $109.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,982.83 | 2019 | |
| Pfizer INC. | $366.39 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $350.34 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $238.51 | 2019-2025 | Camzyos |
| Amgen INC. | $186.24 | 2019-2025 | Repatha |
| Biotronik INC. | $115.85 | 2019 | |
| Astellas Pharma US INC | $109.46 | 2019 | |
| Sanofi-Aventis U.S. LLC | $60.59 | 2019 | |
| Abbott Laboratories | $59.00 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.58 | 2019-2020 | |
| Amarin Pharma, INC. | $55.66 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $49.98 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $44.97 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $31.66 | 2019 | |
| Irhythm Technologies, INC. | $26.35 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $24.07 | 2019 | |
| Atricure, INC. | $22.35 | 2025 | Epi-Ease Epicardial Access System |
| Lundbeck LLC | $19.80 | 2020 | |
| Boston Scientific Corporation | $18.59 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $17.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adel Soliman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.